The Pharmaceutical Strategy for Europe – A Game-Changer for the…
On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy for Europe with the stated aim of ensuring that “patients have access…
Tagged with Innovation
US Pharma Innovation Factsheet 2020
In a recent article for PharmaBoardroom, Objective Capital’s David Crean took a look at the state of US innovation today and its long term…
Annalise Eggimann – CEO, Innosuisse
Innosuisse CEO Annalise Eggimann presents the organisation’s renewed mandate as the main Swiss innovation promotion agency, how Innosuisse serves…
Is the USA’s Innovation Leadership Position At-Risk?
David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term sustainability. The life…
Marcel Plattner – President, vips, Switzerland
Marcel Plattner, president of Swiss industry association vips discusses pricing, market access and innovation, as well as the continuing…
Renée C. Amundsen – Global Head of Business Innovation,…
Merck Healthcare’s newly appointed Global Head of Business innovation, Renée C. Amundsen, highlights the numerous opportunities for change…
Henrik Asmussen – General Manager, Amgen Switzerland
In a wide-ranging interview, Henrik Asmussen outlines his priorities for Amgen’s important Swiss affiliate, market access and pricing challenges,…
Erik W. Jakobsen – Partner & Co-Founder, Menon…
Erik W. Jakobsen of Norwegian consultancy Menon Economics gives an overview of the key dynamics at play in Norway’s economy today and the growing…
Urs Vögeli – Managing Director, Janssen Switzerland
Urs Vögeli, managing director for Janssen Switzerland, outlines the importance of the Swiss operations to Janssen, his interesting career journey,…
Stephan Mumenthaler – Director General, scienceindustries,…
scienceindustries’ Stephan Mumenthaler outlines the business-friendly regulation necessary to maintain Swiss life sciences’ competitive edge, how…
Axel Steiger – CEO, Bayer Switzerland
Axel Steiger, CEO and CFO for Bayer Switzerland, outlines the importance of the Swiss operations as one of the key global hubs for Bayer, his…
René P Buholzer – CEO, Interpharma, Switzerland
Interpharma CEO Dr René P Buholzer outlines the holistic strategy that needs to be put in place to maintain Switzerland’s leading position in…
